Browsing: Clinical > Infection control
Continuous mass distribution of azithromycin in northern Ethiopia is effective for trachoma prevention but doesn’t eliminate the disease entirely, according to new research.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Glenn Tillotson gives us an overview of the 14th Biennial Congress of the Anaerobe Society of the Americas, including updates on the microbiome and new therapies.
The first citywide deployment of Wolbachia has proved successful, with no dengue cases reported since Wolbachia became established.
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
In top-line results from a Phase IIa study, Abivax has reported mixed data, although ABX464 did appear to reduce HIV DNA in blood and rectal samples at a higher dose.